This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
ThermoGenesis Holdings Yönetim
Yönetim kriter kontrolleri 3/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Chris Xu
İcra Kurulu Başkanı
US$699.0k
Toplam tazminat
| CEO maaş yüzdesi | 74.2% |
| CEO görev süresi | 6.9yrs |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | 6.6yrs |
| Yönetim Kurulu ortalama görev süresi | 6.7yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$14m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$699k | US$519k | -US$11m |
| Sep 30 2022 | n/a | n/a | -US$10m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$11m |
| Dec 31 2021 | US$748k | US$500k | -US$11m |
| Sep 30 2021 | n/a | n/a | -US$12m |
| Jun 30 2021 | n/a | n/a | -US$12m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$2m | US$505k | -US$16m |
| Sep 30 2020 | n/a | n/a | -US$18m |
| Jun 30 2020 | n/a | n/a | -US$17m |
| Mar 31 2020 | n/a | n/a | -US$12m |
| Dec 31 2019 | US$472k | US$472k | -US$9m |
| Sep 30 2019 | n/a | n/a | -US$13m |
| Jun 30 2019 | n/a | n/a | -US$13m |
| Mar 31 2019 | n/a | n/a | -US$39m |
| Dec 31 2018 | US$653k | US$460k | -US$40m |
| Sep 30 2018 | n/a | n/a | -US$32m |
| Jun 30 2018 | n/a | n/a | -US$32m |
| Mar 31 2018 | n/a | n/a | -US$6m |
| Dec 31 2017 | US$1m | US$216k | -US$6m |
Tazminat ve Piyasa: Chris's total compensation ($USD699.00K) is above average for companies of similar size in the German market ($USD417.54K).
Tazminat ve Kazançlar: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Xu (52 yo)
6.9yrs
Görev süresi
US$699,000
Tazminat
Dr. Xiaochun Xu, also known as Chris, M.B.A. Ph D., is the Founder, Chairman and Chief Executive Officer of Boyalife Group since July 2009.He serves as an Advisor at WI Harper Group. Dr. Xu has been the C...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Board & CEO | 6.9yrs | US$699.00k | Veri yok | |
| CFO & Corporate Secretary | 6.6yrs | US$325.00k | 0.00064% $ 21.6 | |
| COO & Director | 5.8yrs | US$554.00k | 0% $ 0 |
6.6yrs
Ortalama Görev Süresi
52yo
Ortalama Yaş
Deneyimli Yönetim: THRP's management team is seasoned and experienced (6.6 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Board & CEO | 7.6yrs | US$699.00k | Veri yok | |
| COO & Director | 1.8yrs | US$554.00k | 0% $ 0 | |
| Independent Director | 6.7yrs | US$54.50k | 0% $ 0 | |
| Member of Clinical & Scientific Advisory Board | 9.4yrs | Veri yok | Veri yok | |
| Member of Clinical Advisory Board | 7.6yrs | Veri yok | Veri yok | |
| Independent Director | less than a year | US$99.00k | Veri yok | |
| Independent Director | 6.8yrs | US$56.00k | 0% $ 0 | |
| Independent Director | less than a year | Veri yok | Veri yok |
6.7yrs
Ortalama Görev Süresi
57yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: THRP's board of directors are considered experienced (6.7 years average tenure).